Nanovis built implants to prove its nanotechnology. Now the technology is the business.
Jeff Shepherd, Chief Commercial Officer of Nanovis, explains why the company licensed its nanotechnology to Medtronic and stepped back from spine hardware, and what device OEMs gain from a nano surface partner.
- Published
- Share

Nanovis’s Chief Commercial Officer on going from building spine implants to partnering with medical device OEMs on nano surface technology.
An Interview with Jeff Shepherd, Chief Commercial Officer, NanovisOur newest Experts in Motion interview is live on The MedTech Digest. Guillaume sat down with Jeff Shepherd, Chief Commercial Officer at our client Nanovis. Guillaume has known Jeff for the better part of a decade.
Jeff tells how Nanovis built its own spine implant business to prove its nanotechnology all the way through manufacturing and FDA clearance. When Medtronic licensed the surface for spinal interbodies, Nanovis stepped back from hardware and put that experience to work for other OEMs.
He also gets practical. He covers the first question an OEM engineering team asks, how a project moves from feasibility to a 510(k) filing, and where he sees the next opportunity for surface technology.
The line that stayed with us: “Their implant. Their brand. Their success.”
If you work at a medical device OEM and a surface question is on your list, this one is worth your time.
Where to go from here
More news
Client news · October 13, 2026Realists opens US operations and launches an American website ahead of NASS 2026
Client news · September 17, 2026Headsafe appoints HeadFirst Dx as US commercialization and distribution partner
Client news · August 4, 2026Realists rebuilds its spine surgery simulation portfolio and launches in the United States